Sandy Spring Bank’s Genomic Health, Inc. GHDX Stock Holding History

Sandy Spring Bank’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-320	Closed	-$9K	–	888
2016 Q4	$9K	Hold	320	–	–	﹤0.01%	683
2016 Q3	$9K	Hold	320	–	–	﹤0.01%	672
2016 Q2	$8K	Hold	320	–	–	﹤0.01%	715
2016 Q1	$8K	Hold	320	–	–	﹤0.01%	734
2015 Q4	$11K	Hold	320	–	–	﹤0.01%	643
2015 Q3	$7K	Buy	+320	New	+$8.25K	﹤0.01%	730

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sandy Spring Bank's GHDX Position: Q1 2017 in Review

Sandy Spring Bank sold out of Genomic Health, Inc. (GHDX) in Q1 2017, closing a stake of 320 shares — an estimated $9K sold.

Sandy Spring Bank first reported a position in GHDX in Q3 2015 and held it in 6 quarters. The position peaked at $11K in Q4 2015. 124 funds tracked by Wall St. Rank hold GHDX as of Q1 2017.

Sandy Spring Bank reported no remaining Genomic Health, Inc. position as of Q1 2017 after selling out during the quarter.
Sandy Spring Bank sold 320 Genomic Health, Inc. shares in Q1 2017, an estimated $9K.
Sandy Spring Bank first reported a position in Genomic Health, Inc. in Q3 2015 and held it in 6 quarters.
Sandy Spring Bank's Genomic Health, Inc. position peaked at $11K in Q4 2015.
124 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2017.

Based on Sandy Spring Bank's 13F filing for Q1 2017, filed 10 May 2017.